Objective: The authors describe two cases of isolated sulfite oxidase defic
iency found in one family. This is a rare autosomal-recessive disorder pres
enting at birth with seizures, severe neurologic disease, and ectopia lenti
s. It can be easily missed with metabolic screening; however, the finding o
f lens subluxation stresses the importance of ophthalmic assessment in maki
ng the diagnosis.
Design: Two observational case reports.
Intervention/Methods: Ophthalmic assessment, biochemical assay for specific
urinary and plasma metabolites, magnetic resonance imaging, and gene seque
ncing were used to make the diagnosis of the disease in the proband. The di
agnosis was subsequently recognized in a previously affected sibling after
the postmortem neuropathology was reviewed. Mutation analysis was performed
on cultured fibroblasts from the proband to identify and categorize the sp
ecific mutation responsible for the disease in the family. From this, futur
e prenatal detection of sulfite oxidase deficiency is possible.
Main Outcome Measures: The diagnosis of sulfite oxidase deficiency was esta
blished in this family, enabling appropriate genetic counseling and recurre
nce risk estimation.
Results: Point mutations were found in both alleles of the sulfite oxidase
gene in the proband. The first is a 623C --> A mutation, which predicts an
A208D substitution, and the second is a 1109C --> A, which predicts an S370
Y substitution. Both residues A208D and S370Y are critical for sulfite oxid
ase activity.
Conclusions isolated sulfite oxidase deficiency is a rare heritable disease
for which mutation analysis can allow accurate prenatal screening. It ofte
n is difficult to diagnose by clinical presentation alone, but the critical
finding of lens subluxation accompanying seizures and diffuse neurologic d
isease in an infant should alert the physician to the diagnosis.